One-Year Study Demonstrates Vision-Sciences' EndoSheath Technology Protects Against Bacterial Contamination of Bronchoscopes
22 oct. 2013 08h00 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Oct. 22, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today that the detailed findings of a twelve-month evaluation of its EndoSheath® technology in...
Evaluation at UK Deployed Field Hospital Demonstrates Advantages of Vision-Sciences' EndoSheath(R) Technology for Bronchoscopy
09 sept. 2013 08h40 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Sept. 9, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Reports First Quarter 2014 Financial Results
12 août 2013 16h30 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Aug. 12, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced financial results for the first quarter of fiscal 2014, ended June 30, 2013. Highlights...
Vision-Sciences to Discuss First Quarter of Fiscal 2014 Results on August 13 Conference Call
01 août 2013 16h30 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Appoints Howard Zauberman as Interim Chief Executive Officer
13 mai 2013 17h01 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., May 13, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Announces Revenue of $4.2 Million for Fourth Quarter and $15.3 Million for Full Year Fiscal 2013
29 avr. 2013 17h30 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., April 29, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2013 Results
23 avr. 2013 17h18 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., April 23, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Announces Launch of Next-Generation Video Endoscopy System
18 mars 2013 16h05 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., March 18, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Appoints Cheryl Pegus, MD, MPH to Board of Directors
12 mars 2013 16h38 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., March 12, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences to Present at Canaccord Genuity Musculoskeletal Conference
06 mars 2013 16h15 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., March 6, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...